Usefulness of the sFlt-1/PlGF ratio in screening for early-onset preeclampsia in the pregnant population of La Rioja
DOI:
https://doi.org/10.66737/ier.zub.352Keywords:
Pre-eclampsia, Soluble fms-like tyrosine kinase 1/placental growth factor ratio, Uterine artery DopplerAbstract
Aim. To evaluate the usefulness of the sFlt-1/PIGF ratio at 36 week of pregnancy to dismiss early preeclampsia. Material and methods. Monocentric cohort study carried out between September 2018 and September 2019. The reference population of our study were all pregnant women in the Autonomous Community of La Rioja whose healthcare is centralized in San Pedro’s Hospital. The target population were all pregnant women with a single gestation who were asymptomatic at the time of screening (morphologic ultrasound at 21st week) and in whom the mean of IP AUt was pathological (> 95th percentile for low-risk pregnant women repeatedly at 21st and 26th week or > 75th percentile for high-risk pregnant women at 21st week). Results. 27 women met the inclusion criteria of our reference population (1896 pregnant women). From these 27 women, 22 of them presented a value of the ratio sFlt-1 / PIGF less than 38, showing a specificity and a negative predictive value of 88% and 100% respectively to dismiss preeclampsia,
continuing a low-risk gestational control. Two pregnant women presented a ratio greater than 85 and both presented adverse events related to the placental insufficiency they suffered, premature detachment of the normal placenta and HELLP syndrome after fetal death. The risk factors for preeclampsia in the first trimester screening and the epidemiological characteristics of the patients with this condition were compared with those who did not develop the disease without finding statistically significant differences. Conclusion. The implementation of a screening based on epidemiological factors in the first trimester together with the Doppler determination mean of IP AUt and the sFlt-1 / PIGF ratio in our population seems to be useful to dismiss early preeclampsia, since it has a high specificity and a negative predictive value, similar to those reported in the literature.
Downloads
References
Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1791–8.
Campbell S. First-trimester screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2005;26:487–9.
Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol. 2007;36:412–9.
Conde-Agudelo A, Lindheimer M. Use of Doppler ultrasonography to predict pre-eclampsia. CMAJ. 2008;179:53–4.
Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacós E. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
Ultrasound Obstet. Gynecol. 2008;3:303–9.
Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet. 2008;102:146–51.
Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic J, Gonçalves LF, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol. 2007;196:326.e1–13.
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. NEJM. 2004; 350:672–83.
Von DP, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens. Pregnancy. 2003;22:14.
Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension. 2007;49:818–24.
World Health Organization. World Health Report 2005: make every mother and child count. Geneva, Switzerland: World Health Organization; 2005. www. Who. Int/whr/2005/whr2005_en.pdf.Accessed March 2, 2008.
Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22:203-12.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mariano Laguna Olmos, Cristina Fernández García, Ana Cristina Ruiz Peña, Carlota Cestafe Caro, Edurne Álvarez Suberviola, Cristina Tejada Lamas, Olivia Lafalla Bernad (Autor/a)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en Zubía conservan los derechos de autor de sus trabajos y autorizan a la revista la primera publicación de los mismos.
Los artículos se publican bajo la licencia Creative Commons Atribución–No Comercial–Compartir Igual (CC BY-NC-SA), que permite su uso, distribución y reproducción en cualquier medio, siempre que se cite adecuadamente la autoría original, no se realice un uso comercial y se mantenga la misma licencia.


